KPC Pharmaceuticals (SHSE:600422) Total Stockholders Equity : ¥5,345 Mil (As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is KPC Pharmaceuticals Total Stockholders Equity?

KPC Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥5,345 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. KPC Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2025 was ¥7.06. The ratio of a company's debt over equity can be used to measure how leveraged this company is. KPC Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.31.

KPC Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for KPC Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KPC Pharmaceuticals Total Stockholders Equity Chart

KPC Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

4,450.66

4,783.34

4,983.02

6,562.48

5,253.65

KPC Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															5,416.03	5,375.45	5,532.50	5,253.65	5,345.43

KPC Pharmaceuticals (SHSE:600422) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

KPC Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(5345.426	-	0)	/	756.976
	=	7.06

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

KPC Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(866.112	+	810.452)	/	5345.426
	=	0.31

KPC Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of KPC Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

KPC Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » KPC Pharmaceuticals Inc (SHSE:600422) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106

Website

http://www.kpc.com.cn

KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.

Executives

Qu Xiao Ru	senior management
Xie Bo	senior management
Meng Li	senior management
Zhong Xiang Gang	senior management
Wu Sheng Long	senior management
Liu Jun Feng	senior management
Wang Lei	senior management
Zhang Meng Xun	senior management
Hu Zhen Bo	senior management
Sun Lei	senior management
Xu Chao Neng	senior management
Wang Jun	senior management
Zhao Jian	senior management
He Qin	Director
Dai Xiao Chang	senior management

KPC Pharmaceuticals Headlines

No Headlines